Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
COVID-19
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention

Participation Requirements

Age
Between 12 years and 85 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04773067
Collaborators
Vaxxinity, Inc.
Investigators
Study Chair: Chang-Yi Wang, Ph.D. United Biomedical